SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0000920465-20-000073
Filing Date
2020-05-14
Accepted
2020-05-14 20:26:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 13182
2 gibsondunn001a01.jpg GRAPHIC 12947
3 gibsondunn002.jpg GRAPHIC 13196
  Complete submission text file 0000920465-20-000073.txt   39516
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)